Effect of resistance training volume on body adiposity, metabolic risk, and inflammation in postmenopausal and older females: Systematic review and meta-analysis of randomized controlled trials.

Paulo Ricardo Prado Nunes, Pâmela Castro-E-Souza, Anselmo Alves de Oliveira, Bruno de Freitas Camilo, Gislaine Cristina-Souza, Lucio Marques Vieira-Souza, Marcelo Augusto da Silva Carneiro
Author Information
  1. Paulo Ricardo Prado Nunes: Department of Body and Human Movement, Minas Gerais State University (UEMG), 37902-092 Passos, MG, Brazil; University Center of Planalto de Araxá (UNIARAXA), 38180-129 Araxá, MG, Brazil; Physical Activity, Health and Ageing Research Group (GPASE), Minas Gerais State University (UEMG), 37902-092 Passos, MG, Brazil; Exercise and Nutrition Research Group (GPEN), Minas Gerais State University (UEMG), 37902-092 Passos, MG, Brazil; Sport Sciences and Physical Exercise Study and Research Group - (GEPCEEX), Minas Gerais State University (UEMG), 37902-092 Passos, MG, Brazil. Electronic address: paulo.nunes@uemg.br.
  2. Pâmela Castro-E-Souza: Metabolism, Nutrition and Exercise Laboratory, Physical Education and Sport Center, Londrina State University (UEL), 86050-070 Londrina, PR, Brazil.
  3. Anselmo Alves de Oliveira: University Center of Planalto de Araxá (UNIARAXA), 38180-129 Araxá, MG, Brazil.
  4. Bruno de Freitas Camilo: Department of Body and Human Movement, Minas Gerais State University (UEMG), 37902-092 Passos, MG, Brazil; Physical Activity, Health and Ageing Research Group (GPASE), Minas Gerais State University (UEMG), 37902-092 Passos, MG, Brazil; Exercise and Nutrition Research Group (GPEN), Minas Gerais State University (UEMG), 37902-092 Passos, MG, Brazil; Sport Sciences and Physical Exercise Study and Research Group - (GEPCEEX), Minas Gerais State University (UEMG), 37902-092 Passos, MG, Brazil.
  5. Gislaine Cristina-Souza: Department of Body and Human Movement, Minas Gerais State University (UEMG), 37902-092 Passos, MG, Brazil; Exercise and Nutrition Research Group (GPEN), Minas Gerais State University (UEMG), 37902-092 Passos, MG, Brazil; Sport Sciences and Physical Exercise Study and Research Group - (GEPCEEX), Minas Gerais State University (UEMG), 37902-092 Passos, MG, Brazil.
  6. Lucio Marques Vieira-Souza: Department of Body and Human Movement, Minas Gerais State University (UEMG), 37902-092 Passos, MG, Brazil; Sport Sciences and Physical Exercise Study and Research Group - (GEPCEEX), Minas Gerais State University (UEMG), 37902-092 Passos, MG, Brazil; Postgraduate Program in Physical Education, Federal University of Sergipe (UFS), 49107-230 São Cristóvão, SE, Brazil.
  7. Marcelo Augusto da Silva Carneiro: Metabolism, Nutrition and Exercise Laboratory, Physical Education and Sport Center, Londrina State University (UEL), 86050-070 Londrina, PR, Brazil.

Abstract

PURPOSE: This meta-analytical study aimed to explore the effects of resistance training (RT) volume on body adiposity, metabolic risk, and inflammation in postmenopausal and older females.
METHODS: A systematic search was performed for randomized controlled trials in PubMed, Scopus, Web of Science, and SciELO. Randomized controlled trials with postmenopausal and older females that compared RT effects on body adiposity, metabolic risk, and inflammation with a control group (CG) were included. Independent reviewers selected the studies, extracted the data, and performed the risk of bias and certainty of the evidence (Grading of Recommendations, Assessment, Development, and Evaluation (GRADE)) evaluations. Total body and abdominal adiposity, blood lipids, glucose, and C-reactive protein were included for meta-analysis. A random-effects model, standardized mean difference (Hedges' g), and 95% confidence interval (95%CI) were used for meta-analysis.
RESULTS: Twenty randomized controlled trials (overall risk of bias: some concerns; GRADE: low to very low) with overweight/obese postmenopausal and older females were included. RT groups were divided into low-volume RT (LVRT, ∼44 sets/week) and high-volume RT (HVRT, ∼77 sets/week). Both RT groups presented improved body adiposity, metabolic risk, and inflammation when compared to CG. However, HVRT demonstrated higher effect sizes than LVRT for glucose (HVRT = -1.19; 95%CI: -1.63 to -0.74; LVRT = -0.78; 95%CI:-1.15 to -0.41) and C-reactive protein (HVRT = -1.00; 95%CI: -1.32 to -0.67; LVRT = -0.34; 95%CI, -0.63 to -0.04)) when compared to CG.
CONCLUSION: Compared to CG, HVRT protocols elicit greater improvements in metabolic risk and inflammation outcomes than LVRT in overweight/obese postmenopausal and older females.

Keywords

References

  1. Menopause. 2012 Dec;19(12):1329-35 [PMID: 22914204]
  2. Sports Med Open. 2021 May 29;7(1):38 [PMID: 34050828]
  3. Int J Environ Res Public Health. 2020 Aug 22;17(17): [PMID: 32842644]
  4. Int J Mol Sci. 2022 Mar 23;23(7): [PMID: 35408868]
  5. Biol Res Nurs. 2018 May;20(3):321-334 [PMID: 29430940]
  6. Exp Gerontol. 2021 Jul 15;150:111398 [PMID: 33965553]
  7. Maturitas. 2007 Apr 20;56(4):350-8 [PMID: 17084566]
  8. Int J Sports Med. 2006 Feb;27(2):143-8 [PMID: 16475061]
  9. Scand J Med Sci Sports. 2018 Oct;28(10):2173-2182 [PMID: 29858504]
  10. Adv Nutr. 2021 Feb 1;12(1):179-196 [PMID: 32804997]
  11. Sports Med. 2021 Jun;51(6):1171-1178 [PMID: 33826122]
  12. Obes Rev. 2022 May;23(5):e13428 [PMID: 35191588]
  13. Am J Epidemiol. 2001 Feb 1;153(3):242-50 [PMID: 11157411]
  14. N Engl J Med. 2011 Mar 03;364(9):829-841 [PMID: 21366474]
  15. Br J Cancer. 2009 Feb 24;100(4):578-82 [PMID: 19223908]
  16. Eur J Appl Physiol. 2015 Sep;115(9):1835-45 [PMID: 25861013]
  17. Endocrine. 2000 Oct;13(2):167-86 [PMID: 11186218]
  18. Diabetes Care. 2007 Sep;30(9):2392-4 [PMID: 17563343]
  19. Nutrients. 2020 Jun 26;12(6): [PMID: 32604889]
  20. Obes Rev. 2021 Feb;22(2):e13137 [PMID: 32896055]
  21. J Strength Cond Res. 2004 Aug;18(3):606-9 [PMID: 15320686]
  22. Climacteric. 2012 Dec;15(6):524-30 [PMID: 22992012]
  23. Obes Sci Pract. 2017 Jan 20;3(2):219-223 [PMID: 28702215]
  24. Obes Rev. 2021 Sep;22(9):e13275 [PMID: 33998135]
  25. Exp Gerontol. 2019 Jul 1;121:10-18 [PMID: 30862526]
  26. Lancet. 2007 Dec 1;370(9602):1829-39 [PMID: 18061058]
  27. BMJ. 2021 Mar 29;372:n71 [PMID: 33782057]
  28. Cancer Prev Res (Phila). 2013 Mar;6(3):188-95 [PMID: 23466816]
  29. Biol Res Nurs. 2021 Apr;23(2):280-292 [PMID: 32938197]
  30. Aging Clin Exp Res. 2021 Nov;33(11):2941-2952 [PMID: 33880736]
  31. Age (Dordr). 2016 Apr;38(2):40 [PMID: 26984105]
  32. Aging Cell. 2022 Jun;21(6):e13621 [PMID: 35509177]
  33. Med Sci Sports Exerc. 2009 Feb;41(2):459-71 [PMID: 19127177]
  34. Biores Open Access. 2020 Mar 17;9(1):80-85 [PMID: 32219014]
  35. J Am Med Dir Assoc. 2019 Jul;20(7):830-834.e2 [PMID: 30902674]
  36. Ann Intern Med. 2015 Dec 1;163(11):827-35 [PMID: 26551006]
  37. Arch Gerontol Geriatr. 2019 Mar - Apr;81:171-175 [PMID: 30594892]
  38. J Strength Cond Res. 2021 Jan 1;35(1):1-8 [PMID: 31306389]
  39. Med Sci Sports Exerc. 2005 Feb;37(2):204-12 [PMID: 15692314]
  40. Endocr Relat Cancer. 2012 Nov 09;19(6):785-92 [PMID: 23033315]
  41. Menopause. 2009 Jan-Feb;16(1):66-72 [PMID: 18779759]
  42. Med Sci Sports Exerc. 2009 Jul;41(7):1510-30 [PMID: 19516148]
  43. Med Sci Sports Exerc. 2011 Jul;43(7):1334-59 [PMID: 21694556]
  44. Med Sci Sports Exerc. 2012 Nov;44(11):2099-110 [PMID: 22874536]
  45. Int J Obes Relat Metab Disord. 2000 Feb;24(2):226-31 [PMID: 10702775]
  46. Obstet Gynecol Int. 2010;2010:156037 [PMID: 20490353]
  47. Br J Sports Med. 2020 Mar;54(6):341-348 [PMID: 29934430]
  48. Exp Gerontol. 2018 Oct 1;111:188-196 [PMID: 30071283]
  49. Breast Cancer Res Treat. 2016 Jan;155(2):345-54 [PMID: 26740213]
  50. Endocr Rev. 2002 Feb;23(1):90-119 [PMID: 11844745]
  51. Int J Obes (Lond). 2021 May;45(5):982-997 [PMID: 33558643]
  52. Menopause. 2014 Nov;21(11):1234-8 [PMID: 24714626]
  53. Maturitas. 2008 Apr 20;59(4):394-404 [PMID: 18499368]
  54. Atherosclerosis. 2018 Jul;274:162-171 [PMID: 29783064]
  55. Am J Clin Nutr. 2000 Sep;72(3):694-701 [PMID: 10966886]
  56. J Sport Health Sci. 2023 Mar;12(2):147-157 [PMID: 36351545]
  57. Int J Obes Relat Metab Disord. 2002 Jan;26(1):33-9 [PMID: 11791144]
  58. Sports Med. 2010 May 1;40(5):397-415 [PMID: 20433212]
  59. Diabetes Obes Metab. 2006 Sep;8(5):538-54 [PMID: 16918589]
  60. Endocr J. 2017 Sep 30;64(9):881-894 [PMID: 28717063]
  61. J Diabetes. 2018 Apr;10(4):328-337 [PMID: 29031002]
  62. Nat Rev Drug Discov. 2014 Jun;13(6):465-76 [PMID: 24854413]
  63. Exp Gerontol. 2016 Nov;84:80-87 [PMID: 27616162]
  64. PLoS One. 2013;8(2):e56415 [PMID: 23409182]
  65. N Engl J Med. 2008 Nov 13;359(20):2105-20 [PMID: 19005195]
  66. Endocrinol Metab Clin North Am. 2015 Sep;44(3):663-76 [PMID: 26316249]
  67. J Sports Med Phys Fitness. 2014 Jun;54(3):317-25 [PMID: 24739294]
  68. BMJ. 2019 Aug 28;366:l4898 [PMID: 31462531]
  69. Med Sci Sports Exerc. 2009 Mar;41(3):687-708 [PMID: 19204579]
  70. Diabetes Care. 2015 Jul;38(7):1356-64 [PMID: 25877811]
  71. Clin Nutr. 2023 Mar;42(3):337-351 [PMID: 36736057]
  72. Clin Interv Aging. 2013;8:1221-8 [PMID: 24072967]
  73. Obes Res. 2003 Sep;11(9):1055-64 [PMID: 12972675]
  74. Br J Sports Med. 2020 Dec;54(24):1451-1462 [PMID: 33239350]
  75. J Br Menopause Soc. 2005 Jun;11(2):45-50 [PMID: 15970014]
  76. Curr Vasc Pharmacol. 2019;17(6):595-603 [PMID: 30179134]
  77. J Strength Cond Res. 2020 Oct;34(10):2996-3002 [PMID: 30273288]
  78. J Clin Endocrinol Metab. 1998 Mar;83(3):847-50 [PMID: 9506738]
  79. PLoS One. 2013 Jun 27;8(6):e67349 [PMID: 23826274]
  80. Int J Behav Nutr Phys Act. 2021 Jun 30;18(1):82 [PMID: 34193157]
  81. Adv Nutr. 2015 Sep 15;6(5):592-9 [PMID: 26374181]
  82. Sports Med. 2022 Feb;52(2):287-300 [PMID: 34536199]
  83. Obes Rev. 2012 Jan;13(1):68-91 [PMID: 21951360]
  84. Sci Rep. 2020 Nov 16;10(1):19837 [PMID: 33199796]
  85. J Am Coll Cardiol. 2005 May 17;45(10):1563-9 [PMID: 15893167]
  86. BMC Public Health. 2017 Apr 5;17(1):300 [PMID: 28381272]
  87. Am Heart J. 2005 Jan;149(1):54-60 [PMID: 15660034]
  88. Menopause. 2022 Dec 1;29(12):1430-1440 [PMID: 36219807]
  89. Med Sci Sports Exerc. 2010 Jul;42(7):1286-95 [PMID: 20019638]
  90. Menopause. 2012 Sep;19(9):1015-21 [PMID: 22473250]
  91. Int J Behav Nutr Phys Act. 2022 Mar 12;19(1):25 [PMID: 35279187]
  92. Br J Sports Med. 2002 Oct;36(5):340-4 [PMID: 12351331]
  93. Int J Sports Med. 2018 Jul;39(7):527-534 [PMID: 29775988]
  94. Appl Physiol Nutr Metab. 2010 Dec;35(6):763-72 [PMID: 21164547]
  95. Lancet Glob Health. 2020 Apr;8(4):e511-e523 [PMID: 32199120]
  96. Am J Physiol Endocrinol Metab. 2007 Sep;293(3):E656-65 [PMID: 17578888]
  97. Arch Latinoam Nutr. 2011 Mar;61(1):5-12 [PMID: 22097284]
  98. J Sports Med Phys Fitness. 2018 Apr;58(4):457-464 [PMID: 27735890]
  99. Sports Med. 2013 Feb;43(2):121-33 [PMID: 23329606]

MeSH Term

Female
Humans
Adiposity
C-Reactive Protein
Glucose
Inflammation
Obesity
Overweight
Postmenopause
Randomized Controlled Trials as Topic
Resistance Training

Chemicals

C-Reactive Protein
Glucose

Word Cloud

Created with Highcharts 10.0.0risk-0RTbodyadipositymetabolicinflammationpostmenopausalolderLVRTHVRTfemalescontrolledtrialsCG=-1trainingrandomizedcomparedincludedC-reactiveproteinmeta-analysiseffectsresistancevolumeperformedglucose95%CIlowoverweight/obesegroupssets/week95%CI:63PURPOSE:meta-analyticalstudyaimedexploreMETHODS:systematicsearchPubMedScopusWebScienceSciELORandomizedcontrolgroupIndependentreviewersselectedstudiesextracteddatabiascertaintyevidenceGradingRecommendationsAssessmentDevelopmentEvaluationGRADEevaluationsTotalabdominalbloodlipidsrandom-effectsmodelstandardizedmeandifferenceHedges'g95%confidenceintervalusedRESULTS:Twentyoverallbias:concernsGRADE:dividedlow-volume∼44high-volume∼77presentedimprovedHoweverdemonstratedhighereffectsizes19747895%CI:-115410032673404CONCLUSION:ComparedprotocolselicitgreaterimprovementsoutcomesEffectfemales:SystematicreviewFatmassLipidprofileMenopauseStrength

Similar Articles

Cited By (4)